Advent International

Aimbridge Hospitality Announces Executive Leadership Transitions

Retrieved on: 
Tuesday, November 14, 2023

An Executive Committee of the Board, helmed by Aimbridge Chairman Glenn Murphy has been formed and will lead a comprehensive search for a world class CEO replacement.

Key Points: 
  • An Executive Committee of the Board, helmed by Aimbridge Chairman Glenn Murphy has been formed and will lead a comprehensive search for a world class CEO replacement.
  • Deitemeyer assumed the role of President and CEO of Aimbridge Hospitality in January of 2021 after serving as Global President following the company's merger with Interstate in October 2019.
  • "The addition of Steve Joyce and Bernardo Hees to the Aimbridge Board of Managers brings unparalleled hospitality experience and corporate transformation know-how to our team.
  • To learn more about Aimbridge Hospitality, visit aimbridgehospitality.com .

CCC Intelligent Solutions Announces Pricing of Secondary Offering of 65 Million Shares of Common Stock, Including Concurrent Common Stock Repurchase

Retrieved on: 
Thursday, November 9, 2023

The Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 4,875,000 shares of the Company’s common stock.

Key Points: 
  • The Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 4,875,000 shares of the Company’s common stock.
  • The Offering is expected to close on or about November 13, 2023, subject to the satisfaction of customary closing conditions.
  • The Offering consists entirely of shares of the Company’s common stock to be sold by the Selling Stockholders, and the Company will not receive any proceeds from the sale of the shares being offered by the Selling Stockholders.
  • In connection with the Offering, the Company intends to purchase from the Underwriters 32.5 million shares of the Company’s common stock as part of the Offering at a price per share equal to the price per share at which the underwriters purchase shares of the Company’s common stock in the Offering (the “Concurrent Repurchase”).

CCC Intelligent Solutions Announces Proposed Secondary Offering of 50 Million Shares of Common Stock, including Concurrent Common Stock Repurchase

Retrieved on: 
Wednesday, November 8, 2023

CCC Intelligent Solutions Holdings Inc. (the “Company”) (NASDAQ: CCCS) today announced the proposed secondary offering of 50 million shares of the Company’s common stock (the “Offering”) by affiliates of Advent International, L.P. (the “Selling Stockholders”).

Key Points: 
  • CCC Intelligent Solutions Holdings Inc. (the “Company”) (NASDAQ: CCCS) today announced the proposed secondary offering of 50 million shares of the Company’s common stock (the “Offering”) by affiliates of Advent International, L.P. (the “Selling Stockholders”).
  • The Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of the Company’s common stock.
  • The Offering consists entirely of shares of the Company’s common stock to be sold by the Selling Stockholders, and the Company will not receive any proceeds from the sale of the shares being offered by the Selling Stockholders.
  • In connection with the Offering, the Company intends to purchase from the Underwriters 25 million shares of the Company’s common stock as part of the Offering at a price per share equal to the price per share at which the underwriters purchase shares of the Company’s common stock in the Offering (the “Concurrent Repurchase”).

Baxter Reports Third-Quarter 2023 Results

Retrieved on: 
Thursday, November 2, 2023

Under the terms of the definitive agreement, Baxter received total proceeds of $4.25 billion, subject to adjustment for specified items.

Key Points: 
  • Under the terms of the definitive agreement, Baxter received total proceeds of $4.25 billion, subject to adjustment for specified items.
  • Baxter currently expects the Kidney Care spinoff to occur by July 2024 or earlier, subject to the satisfaction of customary conditions.
  • Baxter expects sales growth from continuing operations of 1% to 2% on a reported basis and approximately 1% on a constant currency basis.
  • A webcast of Baxter’s third-quarter 2023 conference call for investors can be accessed live from a link on the company’s website at www.baxter.com beginning at 7:30 a.m. CDT on Nov. 2, 2023.

Ansira Hosts Fourth Annual Client Summit February 26-28, 2024

Retrieved on: 
Thursday, October 26, 2023

ST. LOUIS, Oct. 26, 2023 /PRNewswire/ -- Ansira Partners, Inc. ("Ansira"), an independent global marketing services and solutions company with proprietary channel, website, and advertising technology, today announced that The Channel Effect, its annual client summit, will take place February 26-28, 2024. The event brings together Ansira's client community which spans multiple industries including technology, automotive, financial services & insurance, restaurants, consumer packaged goods, and retail, to learn from industry experts and peers on hot marketing topics, solutions, and best practices.

Key Points: 
  • ST. LOUIS, Oct. 26, 2023 /PRNewswire/ -- Ansira Partners, Inc. ("Ansira"), an independent global marketing services and solutions company with proprietary channel, website, and advertising technology, today announced that The Channel Effect, its annual client summit, will take place February 26-28, 2024.
  • "We hosted our first Ansira client summit in 2019 with the hopes of both connecting with our clients, but also connecting our clients to each other, giving them the opportunity to experience the work we do across different industry verticals," said Ansira President Andy Arnold.
  • "Every year, we challenge ourselves to raise the bar for the client summit and 2024 will bring a new level of thought leadership, entertainment, and surprise and delight," said Arnold.
  • Ansira is backed by Advent International, one of the largest and most experienced global private equity investors, with deep expertise in the business and financial services sector.

EQS-News: Atlantic BidCo launches public tender offer to initiate the delisting of Aareal Bank – Shareholders can tender remaining shares from today

Retrieved on: 
Thursday, October 26, 2023

Upon the delisting, Aareal Bank shareholders will no longer have access to a regulated market for Aareal Shares.

Key Points: 
  • Upon the delisting, Aareal Bank shareholders will no longer have access to a regulated market for Aareal Shares.
  • Frankfurt, 19 October 2023 – Atlantic BidCo GmbH (“Atlantic BidCo” or the “Bidder”) today published a public delisting tender offer (the “Delisting Offer”) for all remaining outstanding shares of Aareal Bank AG (“Aareal Bank”).
  • During this time, Aareal Bank shareholders can accept the Delisting Offer and tender their shares to the Bidder.
  • Upon the delisting, Aareal Bank shareholders will no longer have access to a regulated market for Aareal Shares.

Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma

Retrieved on: 
Tuesday, October 24, 2023

MIAMI and PERTH, Australia, Oct. 24, 2023 /PRNewswire/ -- Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, announced today that Cyrus K. Mirsaidi is taking the worldwide helm as CEO, including its pharmaceutical supplier division, LumaCina, and its Contract Development and Manufacturing Organization (CDMO) division, NovaCina.

Key Points: 
  • "We are thrilled to have Cyrus stepping into this important role," said Dr. Masood Tayebi, Co-Founder and Chief Executive Officer of Bridgewest Group.
  • This is the same kind of growth and exciting future we see for Bridgewest Perth Pharma; we could not be in better hands," added Tayebi.
  • I am honoured to lead this important strategic mission for Bridgewest Perth Pharma and our dedicated teams," said Mirsaidi.
  • In April, Bridgewest Group announced the acquisition of the Pfizer Perth cGMP sterile injectable manufacturing plant , and the formation of Bridgewest Perth Pharma, including the NovaCina CDMO division and LumaCina pharmaceutical supply division .

Jim McCarthy Named as Thredd CEO

Retrieved on: 
Thursday, October 19, 2023

Thredd , the fast-growing ‘next-gen’ issuer payments platform, appointed Jim McCarthy to succeed Kevin Schultz as CEO, effective immediately, as Schultz will retire later this year.

Key Points: 
  • Thredd , the fast-growing ‘next-gen’ issuer payments platform, appointed Jim McCarthy to succeed Kevin Schultz as CEO, effective immediately, as Schultz will retire later this year.
  • “I’m immensely proud of what we have accomplished at Thredd since I joined – we have successfully implemented a new strategy and repositioned the company for sustainable growth,” said Kevin Schultz, outgoing CEO.
  • “With Jim taking the reins, supported by owners who are committed to our continued success, Thredd is well placed as it enters an exciting new phase.
  • “We would like to thank Kevin for his enormous contribution to the company as CEO, and the key role he has played in its success and transformation during this time.”
    “I’m extremely excited to take on the role of CEO at Thredd,” said Jim McCarthy.

Barclays appoints Jed Brody as Head of Americas Healthcare Banking

Retrieved on: 
Thursday, October 19, 2023

Barclays today announces the appointment of Jed Brody as a Managing Director and Head of Americas Healthcare Banking.

Key Points: 
  • Barclays today announces the appointment of Jed Brody as a Managing Director and Head of Americas Healthcare Banking.
  • Mr. Brody will be based in New York, and report to Rick Landgarten, Global Head of Healthcare and Real Estate Investment Banking.
  • Other recent hires and appointments in Barclays’ Healthcare Investment Banking group include Jon Swope being appointed to the Healthcare Information Technology Banking team, and Maneet Singh and Evan Matlin being named Co-Heads of M&A Healthcare in the US.
  • In addition, Jim Birchenough was appointed as Chairman of Global Healthcare Investment Banking and Co-Head of Global Biopharma Investment Banking, Alexis de Rosnay as Co-Head of Global Biopharma Investment Banking and Chairman of Global Healthcare Investment Banking, and Jeff Ammerman as Global Head of Specialty Pharmaceuticals Investment Banking.

Ansira Announces Integration with Google Merchant Center to Automate Vehicle Ads

Retrieved on: 
Thursday, October 19, 2023

ST. LOUIS, Oct. 19, 2023 /PRNewswire/ -- Ansira Partners, Inc. ("Ansira"), an independent global marketing services and solutions company with proprietary channel, website, and advertising technology, today announced its new integration with Google Merchant Center to help automotive dealers simplify and automate the creation and submission of vehicle ad feeds.

Key Points: 
  • ST. LOUIS, Oct. 19, 2023 /PRNewswire/ -- Ansira Partners, Inc. ("Ansira"), an independent global marketing services and solutions company with proprietary channel, website, and advertising technology, today announced its new integration with Google Merchant Center to help automotive dealers simplify and automate the creation and submission of vehicle ad feeds.
  • "Our new integration with Google Merchant Center helps dealerships run more efficiently by streamlining the vehicle ad process, all while effectively reaching potential in-market buyers."
  • Ansira deploys a custom-built technology solution to create vehicle ad feeds by crawling dealership websites and relevant automated data collection efforts.
  • Through this solution, Ansira can update vehicle feeds every 24 hours to ensure dealerships are showcasing their most up-to-date inventory to potential customers.